References
- Bone marrow autotransplantation in man. Report of an international cooperative study. Lancet 1986; 2: 960–962
- Diagnostic and Therapeutic Technology and Assessment (DAT-TA). Autologous bone marrow transplantation. J Am Med Assoc 1986; 256: 98–101
- Appelbaum FR. Hammering away at solid tumors. Cancer Treat Rep 1987; 71: 115–117
- Phillips GL, Connors JM. Bone Marrow transplantation for malignant lymphoma. Progress in Bone Marrow Transplantation, RP. Gale, R. Champlin. Alan R Liss, Inc., New York 1987; 799–825
- Canellos GP, Nadler L, Takvorian T. Autologous bone marrow transplantation in the treatment of malignant lymphoma and Hodgkin's disease. Semin Hematol 1988; 25: 58–65, suppl 2
- Kersey JH, Weisdorf P, Nesbit ME, et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med 1987; 37: 461–467
- Yeager AM, Kaizer H, Santos GW, et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, usingex vivomarrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 1986; 315: 141–147
- Phillips GL, Fay JW, Herzig GP, et al. Intensive 1,3bis(2-chlorethyl)-1-nitrosourea (BCNU), NSC 436 6650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study. Cancer 1983; 52: 1792–1802
- Lazarus H, Herzig R, Graham-Pole J, et al. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer. J Clin Oncol 1983; 2: 359–367
- Herzig RH, Phillips GL, Lazarus HM, et al. Intensive chemotherapy and autologous bone marrow transplantation for the treatment of refractory malignancies. Autologous Bone Marrow Transplantation: Procedeings of the First International Symposium. University of Texas, M.D. Anderson Hospital and Tumor Institute, Houston, TX 1984
- Peters WP, Eder JP, Henner WD, et al. High-dose combination alkylating agents with autologous bone marrow support: A phase I trial. J Clin Oncol 1986; 4: 646–654
- Antman K, Gale RP. Advanced breast cancer. High-dose chemotherapy and bone marrow autotransplants. Ann Intern Med 1988; 108: 570–574
- Frei E, III, Canellos GP. Dose. A critical factor in cancer chemotherapy. Am J Med 1980; 69: 585–594
- Henderson IC, Hayes DF, Gelman R. Dose-response in the treatment of breast cancer: A critical review. J Clin Oncol 1988; 6: 1501–1515
- Peters WP, Shpall EJ, Jones RB, et al. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 1988; 6: 1368–1376
- Rudnick S, Cadman EC, Capizzi RL, et al. High-dose cytosine arabinoside in refractory acute leukemia. Cancer 1979; 44: 1189–1193
- Herzig RH, Wolff GN, Lazarus HM, et al. High-dose cytosine arabinoside therapy for refractory leukemia. Blood 1983; 62: 361–369
- Wolff SN, Marion J, Stein RS, et al. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: A pilot study. Blood 1985; 65: 1407–1411
- Pritchard J, Garmond S, Jones D, et al. Is high dose melphalan of value in treatment of advanced neuroblastoma? Preliminary results of a randomized trial by the European Neuroblastoma Study Group. Proc Am Soc Clin Oncol 1986; 5: 205
- Gulati SC, Shank B, Black P, et al. Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. J Clin Oncol 1988; 6: 1303–1313
- Welch HG, Larson EB. Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. N Engl J Med 1989; 321: 807–812
- Wittes RE. Paying for patient care in treatment research: Who is responsible?. Cancer Treat Rep 1987; 71: 107–113
- Antman K, Schnipper LE, Frei E. The crisis in clinical cancer research: Third party insurance and investigational therapy. N Engl J Med 1988; 319: 46–48